Understanding the order of genetic changes that lead to Wilms tumour to improve treatment
Ordering of driver mutations in bilateral Wilms’ tumour
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Ordering of driver mutations in bilateral Wilms’ tumour
Epigenetic deregulation of splicing in childhood renal malignancies
Improving the diagnosis of children’s brain tumours by Functional Radiomics
Histopathology of lymphomas in children with primary immune deficiency
Investigating the arginine auxotrophy of paediatric brain tumours
Developing leukaemic biomarkers to enable personalised CNS-directed therapy
Comprehensive molecular characterization of paediatric spinal ependymomas
Investigation of the effects of DNA repair inhibitors in pre-clinical models of neuroblastomas with ATM, MYCN and TP53 abnormalities
Testing the use of mebendazole and albendazole for children with acute myeloid leukaemia, and investigating how the drugs work.